@article{vaquero:hal-01808092, TITLE = {{IGF2/IR/IGF1R pathway in tumor cells and myofibroblasts mediates resistance to EGFR inhibition in cholangiocarcinoma}}, AUTHOR = {Vaquero, Javier and Lobe, Cindy and Tahraoui, Sylvana and Clap{\'e}ron, Audrey and Mergey, Martine and Merabtene, Fatiha and Wendum, Dominique and Coulouarn, C{\'e}dric and Housset, Chantal and Desbois-Mouthon, Christ{\`e}le and Praz, Fran{\c c}oise and Fouassier, Laura}, URL = {https://univ-rennes.hal.science/hal-01808092}, JOURNAL = {{Clinical Cancer Research}}, PUBLISHER = {{American Association for Cancer Research}}, VOLUME = {24}, NUMBER = {17}, PAGES = {4282-4296}, YEAR = {2018}, MONTH = Sep, DOI = {10.1158/1078-0432.CCR-17-3725}, KEYWORDS = {growth-factor receptor ; biliary-tract cancer ; epithelial-mesenchymal transition ; human hepatocellular-carcinoma ; phase-2 trial ; open-label ; insulin ; oxaliplatin ; gemcitabine ; cetuximab}, HAL_ID = {hal-01808092}, HAL_VERSION = {v1}, }